LATEST NEWS

Brazil has a new Minister of Health: Luiz Henrique Mandetta

Date: 02/06/2019

 

Jair Bolsonaro, Brazil’s new president, began his four-year mandate on January 1st. One of the attributions of the new Brazilian leader is the structuring of his team and his ministers are the most important people in this group.

The new Health Minister, Luiz Henrique Mandeta, is a doctor from Campo Grande city, Mato Grosso do Sul state (MT). He was invested in this position on January 2nd. In his inaugural speech he said, “We will write together a new page in public health” and pointed out his priorities: health promotion and disease prevention with the strengthening of Primary Care, strengthening of vaccination rates and computerization of the whole Health network, among others.

About sanitary surveillance and consequently ANVISA’s role, the minister mentioned: “We will reorganize sanitary surveillance so that we will have a more organized, attentive and fast system. Surveillance will do surveillance, and do it well”.

DOMO Salute wishes that the new minister exert his mandate with competency and responsibility, while we will continue performing our mission in the sanitary surveillance field: enabling the access of the new medical technologies to the Brazilian population and strictly enforcing what is predicted in the Brazilian legislation.

Know more about his professional career:

Luiz Hernique Mandetta is a doctor and he has a degree in Orthopedics, with specialization on Pediatrics Orthopedics (Atlanta, Georgia – USA). He has studied Health System and Service Management at FGV, Brazil.

In the beginning of his career, he he was a doctor at HGE and in the 1990s worked at SCCGH and the University Hospital. He taught post-graduate courses at the FUMS. In the early 2000s, he was technical counselor at Santa Casa Hospital, president at Unimed and counselor at Regional Medicine Council of Mato Grosso do Sul.

In the public sector, he was City Health Secretary of Campo Grande city between 2005 and 2010. After this time, he has elected as a congressman by Mato Grosso do Sul State for two mandates (2011 to 2018), where his effort was concentrated on social assistance, mainly in health, medicine, social assists and education, besides being the representative of the of the Brazilian Congress in Mercosur Parlament.

Diego Louzada – Co-founder and Business Developer of Domo Salute

Fonts:

http://portalms.saude.gov.br/o-ministro

http://portalms.saude.gov.br/noticias/agencia-saude/45054-luiz-henrique-mandetta-assume-ministerio-da-saude

http://www.planalto.gov.br/ccivil_03/leis/L9782.htm

MORE NEWS

07/18/2024
  From June 24 to 28, ANVISA participated in the MDSAP Forum and Regulatory Authority Council (RAC) meeting in Essen, Germany. The event gathered representatives from 27 countries, including regulatory authorities, MDSAP auditing organizations, and industry representatives, with notable attendance from Brazilian associations ABIMED and [...]
07/02/2024
  In force since January 2022, RDC 591/2021, which provides for the Unique Device Identification (UDI) system, was amended by ANVISA just days before the deadline for attributing and affixing UDI to risk class IV devices. The amendment was published in RDC 884/2024 on June 1, 2024, and is already in force. According to ANVISA,... Leia [...]
04/12/2024
Marking a significant advancement in regulatory reliance mechanisms, the National Health Surveillance Agency (ANVISA) published Normative Instruction (IN) 290/2024, on April 8, 2024. This normative introduces an optimized procedure for evaluating and deciding on registration petitions for medical devices previously regulated in recognized [...]
03/22/2024
Important Regulatory Update for Manufacturers under MDSAP in Brazil Today, ANVISA has announced a significant regulatory development with the publication of Resolution RDC 850/2024. This regulation brings forth a crucial amendment concerning the validity period of the Brazilian Good Manufacturing Practices (BGMP) Certificate for manufacturers [...]
01/05/2024
Collegiate Board Resolution (RDC) 837/2023, published by ANVISA on December 15th, 2023, brings updates to the rules regarding clinical investigations with medical devices performed in Brazil. Effective immediately from the publication, this resolution aligns Brazilian practices with international standards, providing clearer guidelines for [...]
12/13/2023
On 11 of December 2023, ANVISA published Collegiate Board Resolution – RDC 830/2023, addressing risk classification, registration procedures, as well as labeling requirements and instructions for use of in vitro diagnostic medical devices (IVDs) in Brazil. The new RDC, effective from June 1, 2024, is a comprehensive revision that consolidates [...]
11/28/2023
Public Consultation No. 1.208 will be open to receive contributions until December 9th. In the dynamic landscape of medical device regulations in Brazil, obtaining the Brazilian Good Manufacturing Practices (BGMP) certification is a mandatory request for manufacturers of Class III and Class IV devices seeking Registro. In a recent move towards [...]
03/01/2023
  Starting today – March 1st 2023 – the new Resolution RDC nº 751/2022  comes into force. The Resolution provides for risk classification, Notification and Registro processes, and the requirements for medical devices’ labeling and instructions for use. In order to meet the new requirements and procedures, ANVISA has already [...]
09/22/2022
The Collegiate Board Resolution – RDC 751/2022 was published on the 21st of September 2022, which provides for risk classification, Notification and Registro processes, and the requirements for medical devices’ labeling and instructions for use. The new RDC consolidates the risk classification and regularization regimes for all risk [...]